vs
Side-by-side financial comparison of Affirm Holdings, Inc. (AFRM) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
Affirm Holdings, Inc. is the larger business by last-quarter revenue ($401.4M vs $339.0M, roughly 1.2× HAEMONETICS CORP). Affirm Holdings, Inc. runs the higher net margin — 32.3% vs 13.2%, a 19.1% gap on every dollar of revenue. On growth, Affirm Holdings, Inc. posted the faster year-over-year revenue change (32.5% vs -2.7%). Affirm Holdings, Inc. produced more free cash flow last quarter ($118.0M vs $87.2M). Over the past eight quarters, Affirm Holdings, Inc.'s revenue compounded faster (43.5% CAGR vs 0.4%).
Affirm Holdings, Inc. is an American financial technology company and a point-of-sale lender. Founded in 2012 by PayPal co-founder Max Levchin, it is the largest U.S. based buy now, pay later (BNPL) financier. As of 2025, Affirm reports nearly 26 million users and processing $37 billion in annual payments.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
AFRM vs HAE — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $401.4M | $339.0M |
| Net Profit | $129.6M | $44.7M |
| Gross Margin | — | 59.7% |
| Operating Margin | 29.3% | 19.9% |
| Net Margin | 32.3% | 13.2% |
| Revenue YoY | 32.5% | -2.7% |
| Net Profit YoY | 61.3% | 19.3% |
| EPS (diluted) | $0.37 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $401.4M | $339.0M | ||
| Q3 25 | $320.5M | $327.3M | ||
| Q2 25 | $306.6M | $321.4M | ||
| Q1 25 | $272.5M | $330.6M | ||
| Q4 24 | $303.0M | $348.5M | ||
| Q3 24 | $231.8M | $345.5M | ||
| Q2 24 | $224.0M | $336.2M | ||
| Q1 24 | $195.0M | — |
| Q4 25 | $129.6M | $44.7M | ||
| Q3 25 | $80.7M | $38.7M | ||
| Q2 25 | $69.2M | $34.0M | ||
| Q1 25 | $2.8M | $58.0M | ||
| Q4 24 | $80.4M | $37.5M | ||
| Q3 24 | $-100.2M | $33.8M | ||
| Q2 24 | $-45.1M | $38.4M | ||
| Q1 24 | $-133.9M | — |
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% | ||
| Q1 24 | — | — |
| Q4 25 | 29.3% | 19.9% | ||
| Q3 25 | 19.9% | 17.9% | ||
| Q2 25 | 18.9% | 16.8% | ||
| Q1 25 | -3.1% | 21.6% | ||
| Q4 24 | -1.4% | 16.9% | ||
| Q3 24 | -57.2% | 15.0% | ||
| Q2 24 | -32.8% | 11.8% | ||
| Q1 24 | -82.5% | — |
| Q4 25 | 32.3% | 13.2% | ||
| Q3 25 | 25.2% | 11.8% | ||
| Q2 25 | 22.6% | 10.6% | ||
| Q1 25 | 1.0% | 17.5% | ||
| Q4 24 | 26.5% | 10.8% | ||
| Q3 24 | -43.2% | 9.8% | ||
| Q2 24 | -20.2% | 11.4% | ||
| Q1 24 | -68.7% | — |
| Q4 25 | $0.37 | $0.95 | ||
| Q3 25 | $0.23 | $0.81 | ||
| Q2 25 | $0.22 | $0.70 | ||
| Q1 25 | $0.01 | $1.17 | ||
| Q4 24 | $0.23 | $0.74 | ||
| Q3 24 | $-0.31 | $0.66 | ||
| Q2 24 | $-0.13 | $0.74 | ||
| Q1 24 | $-0.43 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5B | $363.4M |
| Total DebtLower is stronger | $9.0B | $1.2B |
| Stockholders' EquityBook value | $3.5B | $911.5M |
| Total Assets | $13.0B | $2.5B |
| Debt / EquityLower = less leverage | 2.54× | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5B | $363.4M | ||
| Q3 25 | $1.4B | $296.4M | ||
| Q2 25 | $1.4B | $292.9M | ||
| Q1 25 | $1.4B | $306.8M | ||
| Q4 24 | $1.2B | $320.8M | ||
| Q3 24 | $1.0B | $299.3M | ||
| Q2 24 | $1.0B | $344.4M | ||
| Q1 24 | $1.3B | — |
| Q4 25 | $9.0B | $1.2B | ||
| Q3 25 | $7.7B | $1.2B | ||
| Q2 25 | $7.6B | $1.2B | ||
| Q1 25 | $7.1B | $1.2B | ||
| Q4 24 | $7.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.5B | $911.5M | ||
| Q3 25 | $3.3B | $849.2M | ||
| Q2 25 | $3.1B | $882.3M | ||
| Q1 25 | $2.9B | $820.8M | ||
| Q4 24 | $2.8B | $906.9M | ||
| Q3 24 | $2.8B | $878.9M | ||
| Q2 24 | $2.7B | $905.4M | ||
| Q1 24 | $2.6B | — |
| Q4 25 | $13.0B | $2.5B | ||
| Q3 25 | $11.5B | $2.4B | ||
| Q2 25 | $11.2B | $2.5B | ||
| Q1 25 | $10.4B | $2.5B | ||
| Q4 24 | $10.5B | $2.5B | ||
| Q3 24 | $10.1B | $2.5B | ||
| Q2 24 | $9.5B | $2.5B | ||
| Q1 24 | $9.2B | — |
| Q4 25 | 2.54× | 1.34× | ||
| Q3 25 | 2.35× | 1.44× | ||
| Q2 25 | 2.48× | 1.39× | ||
| Q1 25 | 2.49× | 1.49× | ||
| Q4 24 | 2.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.67× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $173.7M | $93.6M |
| Free Cash FlowOCF − Capex | $118.0M | $87.2M |
| FCF MarginFCF / Revenue | 29.4% | 25.7% |
| Capex IntensityCapex / Revenue | 13.9% | 1.9% |
| Cash ConversionOCF / Net Profit | 1.34× | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $619.1M | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $173.7M | $93.6M | ||
| Q3 25 | $374.6M | $111.3M | ||
| Q2 25 | $74.6M | $17.4M | ||
| Q1 25 | $210.4M | $116.6M | ||
| Q4 24 | $312.0M | $43.8M | ||
| Q3 24 | $196.9M | $48.8M | ||
| Q2 24 | $68.8M | $-27.4M | ||
| Q1 24 | $208.2M | — |
| Q4 25 | $118.0M | $87.2M | ||
| Q3 25 | $320.2M | $106.3M | ||
| Q2 25 | $23.5M | $13.6M | ||
| Q1 25 | $157.4M | $100.9M | ||
| Q4 24 | $268.1M | $35.2M | ||
| Q3 24 | $152.7M | $39.4M | ||
| Q2 24 | $30.5M | $-33.1M | ||
| Q1 24 | $161.7M | — |
| Q4 25 | 29.4% | 25.7% | ||
| Q3 25 | 99.9% | 32.5% | ||
| Q2 25 | 7.7% | 4.2% | ||
| Q1 25 | 57.7% | 30.5% | ||
| Q4 24 | 88.5% | 10.1% | ||
| Q3 24 | 65.9% | 11.4% | ||
| Q2 24 | 13.6% | -9.8% | ||
| Q1 24 | 82.9% | — |
| Q4 25 | 13.9% | 1.9% | ||
| Q3 25 | 17.0% | 1.5% | ||
| Q2 25 | 16.7% | 1.2% | ||
| Q1 25 | 19.5% | 4.7% | ||
| Q4 24 | 14.5% | 2.5% | ||
| Q3 24 | 19.0% | 2.7% | ||
| Q2 24 | 17.1% | 1.7% | ||
| Q1 24 | 23.8% | — |
| Q4 25 | 1.34× | 2.09× | ||
| Q3 25 | 4.64× | 2.88× | ||
| Q2 25 | 1.08× | 0.51× | ||
| Q1 25 | 75.03× | 2.01× | ||
| Q4 24 | 3.88× | 1.17× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | — | -0.71× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AFRM
| Merchant Network | $328.4M | 82% |
| Virtual Card Network | $73.0M | 18% |
| Commercial Agreement Amazon | $1.9M | 0% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
